Literature DB >> 21048115

Reduced functional avidity promotes central and effector memory CD4 T cell responses to tumor-associated antigens.

Stefano Caserta1, Joanna Kleczkowska, Anna Mondino, Rose Zamoyska.   

Abstract

The effect of TCR signals on the differentiation of memory T cells is poorly defined. Conventional wisdom suggests that high-avidity interactions are best for the selection of vaccine Ag candidates or T cell specificities for adoptive T cell therapy to stimulate robust responses. However, in conditions of Ag persistence, high-avidity clones might exhaust and fail to form long-lived protective memory. We have manipulated the functional avidity of CD4 T cells by reducing expression of Lck, a key kinase involved in TCR triggering. Using a mouse model, we followed tetramer-positive T cells responding to a tumor Ag expressed by an adenocarcinoma. We show that reducing the functional avidity increased effector-effector memory responses and improved the generation of self-renewing, recirculating, tumor Ag-specific memory phenotype CD4 T cells. Moreover, such cells together with wild type CD8 T cells were better able to control tumor growth. Mechanistically, reducing Lck prolonged IL-2 production and cell turnover in the central memory population while reducing expression of exhaustion markers in the face of chronic Ag. Our data indicate that, in situations of persistent Ag challenge, generating T cells with reduced functional avidity may elicit more effective immune responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21048115     DOI: 10.4049/jimmunol.1001867

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Distinct CD4+ helper T cells involved in primary and secondary responses to infection.

Authors:  K Scott Weber; Qi-Jing Li; Stephen P Persaud; Jeff D Campbell; Mark M Davis; Paul M Allen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

2.  In vivo modulation of avidity in highly sensitive CD8(+) effector T cells following viral infection.

Authors:  Beth C Holbrook; Rama D Yammani; Lance K Blevins; Martha A Alexander-Miller
Journal:  Viral Immunol       Date:  2013-08-24       Impact factor: 2.257

3.  The rationale of vectored gene-fusion vaccines against cancer: evolving strategies and latest evidence.

Authors:  Emeline Ragonnaud; Peter Holst
Journal:  Ther Adv Vaccines       Date:  2013-05

4.  Low Antigen Dose in Adjuvant-Based Vaccination Selectively Induces CD4 T Cells with Enhanced Functional Avidity and Protective Efficacy.

Authors:  Rolf Billeskov; Yichuan Wang; Shahram Solaymani-Mohammadi; Blake Frey; Shweta Kulkarni; Peter Andersen; Else Marie Agger; Yongjun Sui; Jay A Berzofsky
Journal:  J Immunol       Date:  2017-03-27       Impact factor: 5.422

Review 5.  Origins of CD4(+) effector and central memory T cells.

Authors:  Marion Pepper; Marc K Jenkins
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

Review 6.  T Cell Fates Zipped Up: How the Bach2 Basic Leucine Zipper Transcriptional Repressor Directs T Cell Differentiation and Function.

Authors:  Martin J Richer; Mark L Lang; Noah S Butler
Journal:  J Immunol       Date:  2016-08-15       Impact factor: 5.422

7.  Adoptive transfer of cytotoxic T lymphocytes targeting two different antigens limits antigen loss and tumor escape.

Authors:  Karen M Kaluza; Timothy Kottke; Rosa Maria Diaz; Diana Rommelfanger; Jill Thompson; Richard Vile
Journal:  Hum Gene Ther       Date:  2012-08-13       Impact factor: 5.695

8.  Antigen affinity and antigen dose exert distinct influences on CD4 T-cell differentiation.

Authors:  Simone Keck; Mathias Schmaler; Stefan Ganter; Lena Wyss; Susanne Oberle; Eric S Huseby; Dietmar Zehn; Carolyn G King
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

9.  Elimination of IL-10-inducing T-helper epitopes from an IGFBP-2 vaccine ensures potent antitumor activity.

Authors:  Denise L Cecil; Gregory E Holt; Kyong Hwa Park; Ekram Gad; Lauren Rastetter; Jennifer Childs; Doreen Higgins; Mary L Disis
Journal:  Cancer Res       Date:  2014-04-28       Impact factor: 12.701

10.  Dynamics of CD4(+) T cell responses against Listeria monocytogenes.

Authors:  Frederik Graw; K Scott Weber; Paul M Allen; Alan S Perelson
Journal:  J Immunol       Date:  2012-10-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.